Intake of Korean Red Ginseng Extract and Saponin Enhances the Protection Conferred by Vaccination with Inactivated Influenza A Virus |
Xu, Mei Ling
(College of Pharmacy, Chung-Ang University)
Kim, Hyoung-Jin (College of Pharmacy, Chung-Ang University) Choi, Yoo-Ri (College of Pharmacy, Chung-Ang University) Kim, Hong-Jin (College of Pharmacy, Chung-Ang University) |
1 | Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, Macdonald GH, McCullers JA. Distinct contributions of vaccineinduced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against infl uenza. Clin Vaccine Immunol 2006;13:981-990. DOI ScienceOn |
2 | Yasui H, Kiyoshima J, Hori T, Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol 1999;6:186-192. |
3 | Mbawuike IN, Zhang Y, Couch RB. Control of mucosal virus infection by infl uenza nucleoprotein-specifi c CD8+ cytotoxic T lymphocytes. Respir Res 2007;8:44. DOI ScienceOn |
4 | Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969. DOI ScienceOn |
5 | Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. DOI ScienceOn |
6 | Chen WH, Toapanta FR, Shirey KA, Zhang L, Giannelou A, Page C, Frieman MB, Vogel SN, Cross AS. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. Immunol Lett 2012;141:227-234. DOI ScienceOn |
7 | Rajput ZI, Hu SH, Xiao CW, Arijo AG. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 2007;8:153-161. DOI ScienceOn |
8 | Nichol KL. Improving infl uenza vaccination rates among adults. Cleve Clin J Med 2006;73:1009-1015. DOI |
9 | Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004;103:133-138. DOI ScienceOn |
10 | Centers for Disease Control and Prevention. Flu vaccine effectiveness: questions and answers for health professionals. Available from: http://www.cdc.gov/flu/professionals/vaccination/effectivenessqa.htm. |
11 | Goodwin K, Viboud C, Simonsen L. Antibody response to infl uenza vaccination in the elderly: a quantitative review. Vaccine 2006;24:1159-1169. DOI ScienceOn |
12 | Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza: United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010;59:1057-1062. |
13 | Foster SL, Moore WP. High-dose infl uenza vaccination in the elderly. J Am Pharm Assoc (2003) 2010;50:546-547. DOI ScienceOn |
14 | Herrera GA, Iwane MK, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves SS, Gargiullo P, Bridges CB. Influenza vaccine effectiveness among 50-64-yearold persons during a season of poor antigenic match between vaccine and circulating infl uenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007;25:154-160. DOI ScienceOn |
15 | Hu S, Concha C, Lin F, Persson Waller K. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 2003;91:29-37. DOI ScienceOn |
16 | Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497. |
17 | Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Protective immunity against infl uenza H5N1 virus challenge in mice by intranasal coadministration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008;380:412-420. DOI ScienceOn |
18 | World Health Organization. Influenza (seasonal): fact sheet no. 211. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. |
19 | Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-344. DOI ScienceOn |
20 | Xu L, Bao L, Lv Q, Deng W, Ma Y, Li F, Zhan L, Zhu H, Ma C, Qin C. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 2010;7:325. DOI ScienceOn |
21 | Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685. DOI ScienceOn |
22 | Prabakaran M, Madhan S, Prabhu N, Geng GY, New R, Kwang J. Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Res 2010;86:180-187. DOI ScienceOn |
23 | Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. Cellular proteins in infl uenza virus particles. PLoS Pathog 2008;4:e1000085. DOI ScienceOn |
24 | Song X, Hu S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009;27:4883-4890. DOI ScienceOn |
25 | Morein B, Sundquist B, Hoglund S, Dalsgaard K, Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984;308:457-460. DOI ScienceOn |
26 | Wu CA, Yang YW. Induction of cell death by saponin and antigen delivery. Pharm Res 2004;21:271-277. DOI ScienceOn |
27 | Kim JY, Kim HY, Kim HJ. Effect of oral administration of Korean red ginseng on influenza A (H1N1) virus infection. J Ginseng Res 2011;35:104-110. 과학기술학회마을 DOI ScienceOn |
28 | Kim SK, Park JH. Trends in ginseng research in 2010. J Ginseng Res 2011;35:389-398. 과학기술학회마을 DOI ScienceOn |
29 | Ernst E. Panax ginseng: An overview of the clinical evidence. J Ginseng Res 2010;34:259-263. 과학기술학회마을 DOI ScienceOn |
30 | Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302. DOI |
31 | Nah SY. Ginseng: recent advances and trends. Korean J Ginseng Sci 1997;21:1-12. 과학기술학회마을 |
32 | Sun HX, Xie Y, Ye YP. Advances in saponin-based adjuvants. Vaccine 2009;27:1787-1796. DOI ScienceOn |
33 | Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984;15:386-391. DOI ScienceOn |
34 | Rivera E, Daggfeldt A, Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet Immunol Immunopathol 2003;91:19-27. DOI ScienceOn |
35 | Skene CD, Sutton P. Saponin-adjuvanted particulate vaccines for clinical use. Methods 2006;40:53-59. DOI ScienceOn |
36 | Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev 2007;12:25-48. |
37 | Wee JJ, Park MK, Chung AS. Biological activities of ginseng and its application to human health. In: Benzie IF, Wachtel-Galor S, eds. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton: CRC Press, 2011. p. 157-174. |